Abstract:OBJECTIVE:To evaluate safety, efficacy, and long-term outcomes of photoselective vaporization of prostate using 120-W HPS GreenLight KTP laser and compare the results with those obtained with 2-micrometer continuous-wave (2 um CW) laser for treatment of patients with benign prostatic hyperplasia (BPH).MATERIALS AND METHODS:One group of 216 patients diagnosed with BPH underwent 120-W KTP laser vaporization of the prostate, while another group of 198 BPH patients underwent 2 um CW laser vaporization. The relevant pre-, peri-, and post-operative parameters were compared between the two therapy groups. Functional results in terms of improvement of International Prostate Symptom Score (IPSS), maximum flow rate (Qmax), and post-void residual (PVR) urine were assessed at 3, 6, 12, and 24 months.RESULTS:BPH was successfully treated with 120-W HPS KTP laser and 2 um CW laser in all patients. There were no significant difference between two patient groups in the baseline characteristics (such as PSA, IPSS, QoL, and Qmax). No major complications occurred intraoperatively (capsule perforation and TUR syndrome) or postoperatively (electric unbalance), and no blood transfusions were required in both groups. Average catheterization time was 1.9±1.3 days for the 120-W PVP and 2.2±1.9 days for the 2 um CW laser treatment. In addition, the hospitalization times were 3.8±1.2days (120-W PVP) and 4.8±1.5 days (2 um CW laser), respectively. The incidence of dysuria and urge incontinence was higher in the 2 um CW laser group (35/198, 24/198) than in the 120 W PVP group (15/216, 10/216). Dramatic improvement was observed in Qmax, IPSS, Qol, and PVR as compared with the respective pre-operative values. The degree of improvement during the follow-up period was comparable in both groups. No significant differences were observed in terms of re-operation rates, bladder neck stricture, and urethral stricture.CONCLUSIONS:Both 120-W HPS laser and 2 um CW laser vaporization present effective treatment options in patients with BPH, but 120-W PVP provides safer therapy with less post-operative complications within the 2-year follow-up period.

High power dual ceralas laser vaporization for benign prostatic hyperplasia

Two Micron Continuous Wave Laser Vaporesection for the Treatment of Benign Prostatic Hyperplasia

Application of 120 W 2 Μm Laser Prostate Vaporesection in the Treatment of Benign Prostatic Hyperplasia

Clinical efficiency of 120W diode laser vaporization for benign prostate hyperplasia：report of 57 cases

Comparison of Vaporization Using 120-W GreenLight Laser Versus 2-Micrometer Continuous Laser for Treating Benign Prostatic Hyperplasia: A 24-Month Follow-Up Study of a Single Center

GreenLight HPS laser 120 W vs diode laser 300 W vaporization of the prostate for the treatment of benign prostatic hyperplasia in Japanese patients: A prospective, single-center, randomized clinical trial

160-Watt Domestic High Power Greenlight Photoselective Vaporization of Large-Gland Benign Prostatic Hyperplasia

Critical Reviews of 1470-Nm Laser Vaporization on Benign Prostatic Hyperplasia.

Two Micron Continuous Wave Laser Vaporesection for the Treatment of High-Risk Senior Patients with Benign Prostatic Hyperplasia

Early Experiences of Contact Laser Vaporization of the Prostate using the 980 nm High Power Diode Laser for Benign Prostatic Hyperplasia

Evaluation of 80-W and 120-W GreenLight Laser Vaporization for Benign Prostatic Hyperplasia in High-Risk Patients

The RevoLix 2 micron continuous wave laser vaporesection for the treatment of high-risk patients with benign prostatic hyperplasia.

Photoselective potassium-titanyl-phosphate laser vaporization prostatectomy for the treatment of high-risk patients with benign prostatic hyperplasia

GreenLight HPS 120-W laser vaporization versus transurethral resection of the prostate for treatment of benign prostatic hyperplasia: a prospective randomized trial.

Clinical Study of Efficacy and Safety of Transurethral Photoselective Laser Vaporization for Benign Prostatic Hyperplasia

Diode Laser Vaporization for Benign Prostate Hyperplasia: Outcome After 126 Procedures

[Transurethral 180 W front-firing GreenLight laser vaporization of the prostate for the treatment of benign prostatic hyperplasia]

A prospective, single-center, randomized clinical trial to evaluate the efficacy of three types of laser vaporization surgeries using a 180-W GreenLight XPS laser, a 300-W diode laser, and a 200-W thulium laser for the treatment of benign prostatic hyperplasia

Study on 2 Μm Laser Vaporesection of the Prostate for the Treatment of Benign Prostatic Hyperplasia(bph)with Large Volume

High power potassium-titanyl-phosphate laser vaporization prostatectomy

The Efficacy and Safety of 2-Μm Continuous Laser in the Treatment of High-Risk Patients with Benign Prostatic Hyperplasia.